Axonics® Files for Premarket Approval with U.S. Food & Drug Administration for its Sacral Neuromodulation System by Carolyn Helms | Dec 4, 2018 | Portfolio News
Poseida Therapeutics Provides Update on Phase 1 Study of P-BCMA-101 CAR-T Product Candidate at the 2018 American Society of Hematology Annual Meeting by Carolyn Helms | Dec 3, 2018 | Portfolio News
Aptinyx Reports Positive Data from Interim Analysis of Exploratory Study of NYX-2925 in Subjects with Fibromyalgia by Carolyn Helms | Dec 3, 2018 | Portfolio News
Inflazome Appoints Dr Thomas Jung as Chief Medical Officer by Carolyn Helms | Nov 29, 2018 | Portfolio News
